Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EXOSC9 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
mRNA | ANP32E | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
mRNA | DTL | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
mRNA | PBRM1 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
mRNA | GIPC1 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-09 |
mRNA | HSF2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-09 |
mRNA | BUB1B | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-09 |
mRNA | XPO5 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-09 |
mRNA | DBR1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-09 |
mRNA | HCFC1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |